•   
  •   
  •   

Reviews Novartis share in Green: Recreation in the second quarter of Covid stress - continued CureVac vaccine production scheduled

21:16  21 july  2021
21:16  21 july  2021 Source:   finanzen.net

Your handy 1949-53 Jaguar XK120 buyer’s guide

  Your handy 1949-53 Jaguar XK120 buyer’s guide After more than a 120 years of constant improvement in car building, it’s easy to look at the XK120 and think “What a sweet old car,” the wistful way you’d look at a Curved Dash Olds or a Benz Patent-Motorwagen. Don’t make the mistake of confusing this glorious Jag for some dusty relic. When it […] The post Your handy 1949-53 Jaguar XK120 buyer’s guide appeared first on Hagerty Media.

The Pharmaconzern Novartis has been better cut out in the second quarter with a significant growth of sales and results than expected by experts.

Andrew Burton/Getty Images © Provided by Finanzen.net Andrew Burton / Getty Images

have contributed to products such as the dandruff of Cosentyx and the heart medication ENTRESTO, but also the daughter Sandoz specialized on reward ceremony developed again how the Swiss announced on Wednesday in Basel. One year ago, the Covid pandemic had burdened the shops, for many people shied back to the doctor. The targets for 2021 confirmed the Stoxx Europe 50 -heavyweight.

At the stock market, the numbers arrived well. With the plus of two percent on the SIX on Wednesday morning, the Novartis shares are now also in the plus this year, but still limits the European selection index or competitors like Roche . Surprisingly high sales and better margins ensured that the pharmaconzern also cut off the result of the earnings per share than intended, Analyst Peter Welford wrote from the investment bank Jefferies in a study. The interest of investors in the stock is still relatively low, but the quarterly report could now provide a slightly positive course reaction.

Chip shortage explained: Low inventory, skyrocketing used car prices and no end in sight

  Chip shortage explained: Low inventory, skyrocketing used car prices and no end in sight Chip shortage explained: Low inventory, skyrocketing used car prices and no end in sight originally appeared on Autoblog on Wed, 5 May 2021 16:40:00 EDT. Please see our terms for use of feeds.

But the Group is not entirely on the stand he had before the pandemic. "I think we are currently 80 to 90 percent of the pre-corona level," said Financial Chef Harry Kirsch in a conference call with journalists. Different therapeutic areas and also individual regions showed great differences. Especially in the area of ​​oncology, the Group is still slightly more clearly removed from business activity, which he saw before the outbreak of the pandemic.

In the second quarter, sales increased by 14 percent year-on-year to just under $ 13 billion (around twelve Mard euros) to constant currencies, the plus nine percent. The lion's share for quarterly sales contributed by the pharmaceutical division, which increased sales in the second annual quarter by 15 percent to $ 10.6 billion. Above all, a persistently strong paragraph of the Härmittel's ENTRESTO, the dandruffmittel Cosentyx and the genera therapy of Zolgensma contributed.

commercial vehicle manufacturer: VW subsidiary Traton reports order record - truck desires, buses less in demand

 commercial vehicle manufacturer: VW subsidiary Traton reports order record - truck desires, buses less in demand After the corona burglary, the commercial vehicle business is recovering and brought traton full order books. More than 80,000 buses and trucks came in the first quarter. © dpa especially trucks and small trucks are in demand in the after-corona upswing. At the VW commercial vehicle holding traton, the business buzzes again.

The Sandoz specialized in adoption ceremonies (generics) has $ 2.4 billion to book an increase in sales of eleven percent. The shops were started to stabilize themselves. However, revenue growth in Europe faced a clear decline in the US. This minus on the US market is mainly due to the business with means sold in retail resources, in particular the orally administered medicines bolted.

In the second quarter, the operating result of Novartis increased by 48 percent to $ 3.5 billion, under the line, the Group earned around 55 percent more than 55 percent with $ 2.9 billion than in the previous year. In addition to higher sales, capital gains contributed to this. In 2021 Novartis continues to raise an increase in sales to constant exchange rates in the low to medium-sized percentage range. Adjusted operational profit should increase more than sales and average single-digit percentage range.

We Found Bike Helmets That Are Actually Safe *And* Stylish (You're Welcome!)

  We Found Bike Helmets That Are Actually Safe *And* Stylish (You're Welcome!) These 20 cute and affordable options prove it.

Novartis Plant Continue Production of the CureVac vaccine This year

The Swiss Pharmaconzern Novartis continues to establish the Covid 19 vaccine of the German biotech company CureVac .

"We started production as planned. We plan to deliver 50 million doses this year," said Novartis Financial Chef Harry Kirsch on Wednesday in a conference call. To the effectiveness of the Corona vaccine or the likelihood of approval, Novartis could not comment. If there is a need for additional production capacities, such as BionTech / Pfizer or other, Novartis can further expand them. "We are not limited to one or the other."

Novartis already supports BIONTECH / PFIZER in the production of your vaccine. The vaccine of CureVac is to be manufactured in the Austrian work Kundl by Novartis. The vaccine achieved only an efficacy of 48 percent in the crucial clinical trial. However, despite the disappointing study results, CureVac will continue to use a use by the European Union.

Basel (DPA-AFX) / Frankfurt (Reuters)

Vaccine Sputnik V: WHO finds problems on a site, Russia says that it is regulated .
the WHO was concerned with a possible lack of traceability inspection - WHO was concerned with 'A possible lack of traceability not touches my vaccine. While inspectors of the World Health Organization (WHO) had pointed on Wednesdays on one of the Russian Sputnik V vaccine production sites, the Kremlin assured that everything had been solved since.

usr: 5
This is interesting!